Fig. 5: Validation of DISCoVER on patient samples. | Nature Biomedical Engineering

Fig. 5: Validation of DISCoVER on patient samples.

From: Rapid detection of SARS-CoV-2 RNA in saliva via Cas13

Fig. 5

a, Schematic of rLAMP multiplexing with SARS-CoV-2 (N gene) and human internal control (RNase P) primer sets. b, DISCoVER signal of SARS-CoV-2-positive saliva samples after multiplexed rLAMP. Values are mean ± s.d. with n = 3 technical replicates. c, Fold change in DISCoVER signal relative to NTC on 30 negative clinical nasal samples at 5 min of Cas13 detection. d, Fold change in DISCoVER signal relative to NTC on 33 positive clinical nasal samples at 5 min of Cas13 detection.

Source data

Back to article page